Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.87−0.03 (-3.33%)
Close on Nov 13, 2026Market cap $14.51MP/E –Yield –
Marker Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Marker Therapeutics's operating margin for the twelve months ending Mar 31, 2026 was -334.6%. For fiscal 2025 it was -363.5%, against -168.7% the year before. The highest annual figure on record is -168.7% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -363.5% | −194.8 |
| FY2024 | Dec 31, 2024 | -168.7% | +271.7 |
| FY2023 | Dec 31, 2023 | -440.4% | +122.9 |
| FY2022 | Dec 31, 2022 | -563.3% | +2616.0 |
| FY2021 | Dec 31, 2021 | -3179.3% | +2597.8 |
| FY2020 | Dec 31, 2020 | -5777.2% | +4790.1 |
| FY2019 | Dec 31, 2019 | -10567.3% | +61362.8 |
| FY2018 | Dec 31, 2018 | -71930.1% | −65659.0 |
| FY2017 | Dec 31, 2017 | -6271.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -541.8% | +878.4 |
| Q4 FY2025 | Dec 31, 2025 | -170.7% | +0.7 |
| Q3 FY2025 | Sep 30, 2025 | -173.3% | −48.7 |
| Q2 FY2025 | Jun 30, 2025 | -594.8% | −397.4 |
| Q1 FY2025 | Mar 31, 2025 | -1420.1% | −1215.2 |
| Q4 FY2024 | Dec 31, 2024 | -171.5% | +106.6 |
| Q3 FY2024 | Sep 30, 2024 | -124.6% | +1117.6 |
| Q2 FY2024 | Jun 30, 2024 | -197.4% | +344.7 |
| Q1 FY2024 | Mar 31, 2024 | -204.9% | +144.2 |
| Q4 FY2023 | Dec 31, 2023 | -278.1% | +122.2 |
| Q3 FY2023 | Sep 30, 2023 | -1242.2% | −659.3 |
| Q2 FY2023 | Jun 30, 2023 | -542.1% | +124.4 |
| Q1 FY2023 | Mar 31, 2023 | -349.1% | +666.6 |
| Q4 FY2022 | Dec 31, 2022 | -400.3% | +25216.1 |
| Q3 FY2022 | Sep 30, 2022 | -582.9% | +779.1 |
| Q2 FY2022 | Jun 30, 2022 | -666.5% | +1848.6 |
| Q1 FY2022 | Mar 31, 2022 | -1015.7% | +1253.2 |
| Q4 FY2020 | Dec 31, 2020 | -25616.4% | −23437.1 |
| Q2 FY2020 | Jun 30, 2020 | -1362.0% | – |
| Q4 FY2019 | Dec 31, 2019 | -2515.1% | – |
| Q2 FY2018 | Jun 30, 2018 | -2268.9% | – |
| Q3 FY2017 | Sep 30, 2017 | -2179.3% | – |
See a number that looks wrong?